Kiromic BioPharma, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 5.3 million compared to USD 7.37 million a year ago. Basic loss per share from continuing operations was USD 6.17 compared to USD 14.39 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.819 USD | +2.88% | -11.35% | +224.02% |
06-07 | Kiromic Biopharma, Inc. Issues 25% Senior Secured Convertible Promissory Note | CI |
06-03 | Kiromic BioPharma, Inc. announced that it has received $2 million in funding | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+224.02% | 4.35M | |
+18.35% | 125B | |
+14.13% | 108B | |
-6.53% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-14.86% | 16.34B | |
+0.22% | 13.56B | |
+25.04% | 11.59B |
- Stock Market
- Equities
- KRBP Stock
- News Kiromic BioPharma, Inc.
- Kiromic BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023